News Focus
News Focus
Followers 8
Posts 389
Boards Moderated 0
Alias Born 08/16/2001

Re: Zeev Hed post# 303761

Thursday, 09/30/2004 2:53:10 PM

Thursday, September 30, 2004 2:53:10 PM

Post# of 704049
Zeev:

For after market regarding MRK.

It is not only the issue of a 10% loss in revenue and related profits (which is a boon to AMGN) but now the trial lawyers will find impacted patients (similar to that diet drug Phen Fen (sp??)) and this can cost billions (YES billions).

So I would revisit the fundamentals of MRK remaining in the core under $35.




Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today